Immunocore
IMCR
IMCR
57 hedge funds and large institutions have $590M invested in Immunocore in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
16% more funds holding
Funds holding: 49 → 57 (+8)
3.77% more ownership
Funds ownership: 41.23% → 45.01% (+3.8%)
8% less capital invested
Capital invested by funds: $642M → $590M (-$52.3M)
Holders
57
Holding in Top 10
3
Calls
$971K
Puts
$11K
Top Buyers
| 1 | +$18.4M | |
| 2 | +$11.8M | |
| 3 | +$11.5M | |
| 4 |
SC
Samlyn Capital
New York
|
+$11.4M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
+$10.9M |
Top Sellers
| 1 | -$14.8M | |
| 2 | -$12.3M | |
| 3 | -$11.8M | |
| 4 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$9.51M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.15M |